SNHG7: A novel vital oncogenic lncRNA in human cancers

Yong Zhou1, Bo Tian1, Jinming Tang2

  • 1Department of the 2nd Department of Thoracic Surgery, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.

Insights

Small nucleolar RNA hostgene 7 (SNHG7), a long noncoding RNA, is frequently overexpressed in various cancers. Its dysregulation drives tumor progression, promoting proliferation and metastasis while inhibiting apoptosis, indicating poor patient prognosis.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Long noncoding RNAs (lncRNAs) regulate gene expression at multiple levels and are implicated in various physiological and pathological processes.
  • Deregulation of lncRNAs contributes to tumor initiation and progression, exhibiting either tumor-suppressive or oncogenic effects.
  • Small nucleolar RNA hostgene 7 (SNHG7) is a lncRNA implicated in the development and progression of multiple human malignancies.

Purpose of the Study:

  • To review the latest insights into the expression patterns of SNHG7 across different human cancers.
  • To elucidate the functional roles and molecular mechanisms of SNHG7 in tumorigenesis.
  • To highlight the prognostic significance of SNHG7 in various malignancies.

Main Methods:

  • Literature review of studies investigating SNHG7 expression and function in human cancers.
  • Analysis of data linking SNHG7 expression levels to patient prognosis and survival outcomes.
  • Examination of molecular mechanisms by which SNHG7 influences cancer cell proliferation, metastasis, and apoptosis.

Main Results:

  • SNHG7 is frequently overexpressed in diverse cancers including bladder, breast, colorectal, esophageal, gastric, and prostate cancer, as well as osteosarcoma.
  • High SNHG7 expression is consistently associated with poor prognosis and reduced survival rates in cancer patients.
  • SNHG7 promotes cancer cell proliferation and metastasis while concurrently inhibiting apoptosis.

Conclusions:

  • SNHG7 plays a significant oncogenic role in the development and progression of multiple human malignancies.
  • SNHG7 serves as a potential diagnostic and prognostic biomarker for various cancers.
  • Targeting SNHG7 may represent a novel therapeutic strategy for cancer treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.0K